Inhibition of IGF-I receptor signaling in combination with rapamycin or temsirolimus increases MYC-N phosphorylation

Donald W Coulter, Mary Beth Wilkie, Billie M. Moats-Staats

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: It has been previously shown that blockade of the type 1 insulin-like growth factor receptor (IGF1R) signaling combined with mTOR inhibition decreased neuroblastoma proliferation in vitro. MYC-N inactivation occurs through phosphorylation by downstream elements of the IGF1R signaling pathway. It was hypothesized that inhibition of IGF1R signaling would increase the inactivation of MYC-N. Materials and Methods: BE-2(c) and IMR-32 neuroblastoma cell lines were treated with varying concentrations of αIR3, rapamycin and temsirolimus either alone or in combination and the expression of MYC-N and phosphorylated MYC-N proteins were evaluated by Western blotting. The number of apoptotic cells was evaluated through cleaved caspase-3 expression. Results: IGF1R signaling blockade in combination with mTOR inhibition decreased MYC-N protein expression, increased MYC-N phosphorylation and significantly increased cleaved caspase-3 expression in treated cells. Conclusion: The combination of rapamycin or temsirolimus with αIR3 decreases MYC-N expression, increases MYC-N phosphorylation and induces apoptosis in vitro which may have clinical relevance to children with neuroblastoma.

Original languageEnglish (US)
Pages (from-to)1943-1949
Number of pages7
JournalAnticancer Research
Volume29
Issue number6
StatePublished - Jun 1 2009

Fingerprint

IGF Type 1 Receptor
Sirolimus
Neuroblastoma
Phosphorylation
Caspase 3
Proto-Oncogene Proteins c-myc
Cell Count
Western Blotting
Apoptosis
Cell Line
temsirolimus
In Vitro Techniques

Keywords

  • IGF-I receptor
  • Neuroblastoma
  • Phosphorylated MYC-N
  • Rapamycin
  • Temsirolimus
  • mTOR

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Inhibition of IGF-I receptor signaling in combination with rapamycin or temsirolimus increases MYC-N phosphorylation. / Coulter, Donald W; Wilkie, Mary Beth; Moats-Staats, Billie M.

In: Anticancer Research, Vol. 29, No. 6, 01.06.2009, p. 1943-1949.

Research output: Contribution to journalArticle

@article{93a4e19578ba4eb59be0ba53cae10bd6,
title = "Inhibition of IGF-I receptor signaling in combination with rapamycin or temsirolimus increases MYC-N phosphorylation",
abstract = "Background: It has been previously shown that blockade of the type 1 insulin-like growth factor receptor (IGF1R) signaling combined with mTOR inhibition decreased neuroblastoma proliferation in vitro. MYC-N inactivation occurs through phosphorylation by downstream elements of the IGF1R signaling pathway. It was hypothesized that inhibition of IGF1R signaling would increase the inactivation of MYC-N. Materials and Methods: BE-2(c) and IMR-32 neuroblastoma cell lines were treated with varying concentrations of αIR3, rapamycin and temsirolimus either alone or in combination and the expression of MYC-N and phosphorylated MYC-N proteins were evaluated by Western blotting. The number of apoptotic cells was evaluated through cleaved caspase-3 expression. Results: IGF1R signaling blockade in combination with mTOR inhibition decreased MYC-N protein expression, increased MYC-N phosphorylation and significantly increased cleaved caspase-3 expression in treated cells. Conclusion: The combination of rapamycin or temsirolimus with αIR3 decreases MYC-N expression, increases MYC-N phosphorylation and induces apoptosis in vitro which may have clinical relevance to children with neuroblastoma.",
keywords = "IGF-I receptor, Neuroblastoma, Phosphorylated MYC-N, Rapamycin, Temsirolimus, mTOR",
author = "Coulter, {Donald W} and Wilkie, {Mary Beth} and Moats-Staats, {Billie M.}",
year = "2009",
month = "6",
day = "1",
language = "English (US)",
volume = "29",
pages = "1943--1949",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Inhibition of IGF-I receptor signaling in combination with rapamycin or temsirolimus increases MYC-N phosphorylation

AU - Coulter, Donald W

AU - Wilkie, Mary Beth

AU - Moats-Staats, Billie M.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Background: It has been previously shown that blockade of the type 1 insulin-like growth factor receptor (IGF1R) signaling combined with mTOR inhibition decreased neuroblastoma proliferation in vitro. MYC-N inactivation occurs through phosphorylation by downstream elements of the IGF1R signaling pathway. It was hypothesized that inhibition of IGF1R signaling would increase the inactivation of MYC-N. Materials and Methods: BE-2(c) and IMR-32 neuroblastoma cell lines were treated with varying concentrations of αIR3, rapamycin and temsirolimus either alone or in combination and the expression of MYC-N and phosphorylated MYC-N proteins were evaluated by Western blotting. The number of apoptotic cells was evaluated through cleaved caspase-3 expression. Results: IGF1R signaling blockade in combination with mTOR inhibition decreased MYC-N protein expression, increased MYC-N phosphorylation and significantly increased cleaved caspase-3 expression in treated cells. Conclusion: The combination of rapamycin or temsirolimus with αIR3 decreases MYC-N expression, increases MYC-N phosphorylation and induces apoptosis in vitro which may have clinical relevance to children with neuroblastoma.

AB - Background: It has been previously shown that blockade of the type 1 insulin-like growth factor receptor (IGF1R) signaling combined with mTOR inhibition decreased neuroblastoma proliferation in vitro. MYC-N inactivation occurs through phosphorylation by downstream elements of the IGF1R signaling pathway. It was hypothesized that inhibition of IGF1R signaling would increase the inactivation of MYC-N. Materials and Methods: BE-2(c) and IMR-32 neuroblastoma cell lines were treated with varying concentrations of αIR3, rapamycin and temsirolimus either alone or in combination and the expression of MYC-N and phosphorylated MYC-N proteins were evaluated by Western blotting. The number of apoptotic cells was evaluated through cleaved caspase-3 expression. Results: IGF1R signaling blockade in combination with mTOR inhibition decreased MYC-N protein expression, increased MYC-N phosphorylation and significantly increased cleaved caspase-3 expression in treated cells. Conclusion: The combination of rapamycin or temsirolimus with αIR3 decreases MYC-N expression, increases MYC-N phosphorylation and induces apoptosis in vitro which may have clinical relevance to children with neuroblastoma.

KW - IGF-I receptor

KW - Neuroblastoma

KW - Phosphorylated MYC-N

KW - Rapamycin

KW - Temsirolimus

KW - mTOR

UR - http://www.scopus.com/inward/record.url?scp=67650921950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650921950&partnerID=8YFLogxK

M3 - Article

C2 - 19528451

AN - SCOPUS:67650921950

VL - 29

SP - 1943

EP - 1949

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -